Table 6.
HDL-C adverse change (AC) rates. Interactions with baseline characteristics
| Control | Exercise | Interaction p-value | |
|---|---|---|---|
|
| |||
| Agea: AC | 54 (41–65) | 54 (45–64) | 0.12 |
| Non-AC | 53 (40–64) | 54 (44–64) | |
|
| |||
| Gender: | 0.68 | ||
| AC female | 28% | 22% | |
| AC male | 21% | 16% | |
|
| |||
| Race/ethnicity: | |||
| AC Caucasian | 28.0% | 19.4% | 0.12 |
| AC Afr-Amer | 20.5% | 23.4% | |
| AC Hisanic/other | 22.7% | 17.1% | |
|
| |||
| BMI: AC | 30 (25–36) | 30 (25–35) | 0.66 |
| Non-AC | 30 (26–36) | 30 (25–36) | |
|
| |||
| Peak VO2: AC | 21.2 (13.0–30.7) | 17.5 (13.7–32.7) | 0.70 |
| Non-AC | 21.0 (13.4–35.0) | 19.8 (12.8–33.7) | |
Continuous variables are reported as: median (10th percentile, 90th percentile)